| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | SPEC | 1.31e-06 | 32 | 113 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.31e-06 | 32 | 113 | 5 | IPR018159 | |
| Domain | Spectrin_repeat | 2.68e-05 | 29 | 113 | 4 | IPR002017 | |
| Domain | SOHO | 1.08e-04 | 3 | 113 | 2 | PS50831 | |
| Domain | Cyclin_D | 1.08e-04 | 3 | 113 | 2 | IPR015451 | |
| Domain | Sorb | 1.08e-04 | 3 | 113 | 2 | SM00459 | |
| Domain | Sorb | 1.08e-04 | 3 | 113 | 2 | PF02208 | |
| Domain | SoHo_dom | 1.08e-04 | 3 | 113 | 2 | IPR003127 | |
| Domain | DCB_dom | 2.16e-04 | 4 | 113 | 2 | IPR032629 | |
| Domain | Sec7_C | 2.16e-04 | 4 | 113 | 2 | IPR015403 | |
| Domain | DUF1981 | 2.16e-04 | 4 | 113 | 2 | PF09324 | |
| Domain | Sec7_N | 2.16e-04 | 4 | 113 | 2 | IPR032691 | |
| Domain | Sec7_N | 2.16e-04 | 4 | 113 | 2 | PF12783 | |
| Domain | DCB | 2.16e-04 | 4 | 113 | 2 | PF16213 | |
| Domain | Spectrin | 3.50e-04 | 23 | 113 | 3 | PF00435 | |
| Domain | RNase_CAF1 | 3.59e-04 | 5 | 113 | 2 | IPR006941 | |
| Domain | CAF1 | 3.59e-04 | 5 | 113 | 2 | PF04857 | |
| Domain | - | 5.36e-04 | 6 | 113 | 2 | 3.90.1290.10 | |
| Domain | Plectin | 7.47e-04 | 7 | 113 | 2 | PF00681 | |
| Domain | Plectin_repeat | 7.47e-04 | 7 | 113 | 2 | IPR001101 | |
| Domain | PLEC | 7.47e-04 | 7 | 113 | 2 | SM00250 | |
| Domain | PHD | 1.11e-03 | 75 | 113 | 4 | PF00628 | |
| Pubmed | XRN2 SORBS2 OGT DSP SYNE1 SPTAN1 MCF2L2 USP25 ARFGEF2 TTC27 SORBS1 HUWE1 ZKSCAN5 CNOT8 CASK TRIM66 PNMA2 MRPS9 MACF1 ZNF528 DYNC1H1 ZMYM4 KPNB1 | 6.84e-11 | 1285 | 119 | 23 | 35914814 | |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 2.90e-09 | 104 | 119 | 8 | 31240132 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | XRN2 SORBS2 DSP SPTAN1 USP24 ARFGEF2 GEMIN5 HUWE1 TBC1D9 BPTF PDIA6 PAXBP1 CTDP1 MICAL3 KAT6B ZMYM4 | 9.94e-09 | 774 | 119 | 16 | 15302935 |
| Pubmed | CTNNAL1 CDC42BPA DSP USP24 XPNPEP1 OPA1 ADCY9 TBC1D8 PDIA6 MACF1 MICAL3 EIF2AK3 DYNC1H1 GAB1 KPNB1 | 2.16e-08 | 708 | 119 | 15 | 39231216 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | CTNNAL1 OGT RNGTT TTC27 HUWE1 ECM1 OPA1 CASK PDIA6 IGF2BP1 AGL PRKAA1 UGDH PNMA2 TMEM131L HOOK2 KPNB1 | 3.92e-08 | 974 | 119 | 17 | 28675297 |
| Pubmed | UBR2 CTNNAL1 RNGTT CDC42BPA DSP SPTAN1 TTC27 HUWE1 OPA1 ADCY9 CASK PHF2 PDIA6 PNMA2 MICAL3 GAB1 KPNB1 | 1.13e-07 | 1049 | 119 | 17 | 27880917 | |
| Pubmed | CDC42BPA DSP SYNE1 DGKD SORBS1 AGL UGDH MACF1 HOOK2 ZMYM4 MYBPC1 KPNB1 | 1.51e-07 | 497 | 119 | 12 | 23414517 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | UBR2 OGT CDC42BPA EPB41L4B CCND1 PFKFB4 HUWE1 ECH1 CASK PHF2 ZNF708 BPTF SLC22A3 FNIP1 MACF1 MICAL3 ZNF528 HOOK2 KAT6B ZMYM4 | 1.62e-07 | 1489 | 119 | 20 | 28611215 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | XRN2 SORBS2 OGT CDC42BPA DSP SYNE1 SPTAN1 OPA1 CASK PHF2 BPTF PDIA6 IGF2BP1 PAXBP1 MACF1 DYNC1H1 KPNB1 | 1.75e-07 | 1082 | 119 | 17 | 38697112 |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 1.99e-07 | 120 | 119 | 7 | 31413325 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 4.21e-07 | 197 | 119 | 8 | 20811636 | |
| Pubmed | RNGTT CDC42BPA EFCAB6 EPB41L4B ARFGEF2 ARFGEF1 HUWE1 ADCY9 CASK IGF2BP1 UGDH MRPS9 DYNC1H1 GAB1 | 4.67e-07 | 777 | 119 | 14 | 35844135 | |
| Pubmed | UBR2 XRN2 OGT DSP SPTAN1 ARFGEF2 ARFGEF1 GEMIN5 BPTF AGL KPNB1 | 1.13e-06 | 494 | 119 | 11 | 26831064 | |
| Pubmed | UBR2 SORBS2 SYNE1 SORBS1 OPA1 FNIP1 MACF1 MICAL3 DYNC1H1 ADGRL3 | 1.48e-06 | 407 | 119 | 10 | 12693553 | |
| Pubmed | 1.54e-06 | 234 | 119 | 8 | 36243803 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | OGT DSP SPTAN1 USP24 TTC27 GEMIN5 HUWE1 ECH1 OPA1 PDIA6 IGF2BP1 PAXBP1 AGL PRKAA1 MRPS9 MACF1 DYNC1H1 KPNB1 | 1.57e-06 | 1415 | 119 | 18 | 28515276 |
| Pubmed | SORBS2 OGT EPB41L4B DSP SYNE1 SPTAN1 ARFGEF2 GEMIN5 SORBS1 OPA1 CASK PDIA6 PRKAA1 MRPS9 MACF1 MICAL3 DYNC1H1 KPNB1 | 1.84e-06 | 1431 | 119 | 18 | 37142655 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | XRN2 DSP SPTAN1 CCND1 HUWE1 ADGRG4 CASK CCND2 IGF2BP1 TRAP1 MRPS9 HOOK2 | 2.12e-06 | 639 | 119 | 12 | 23443559 |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 4.20e-06 | 358 | 119 | 9 | 32460013 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | XRN2 DSP SPTAN1 USP24 ARFGEF2 HUWE1 TRAP1 MACF1 USP48 DYNC1H1 KPNB1 | 5.42e-06 | 582 | 119 | 11 | 20467437 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | KIF13B XRN2 OGT RNGTT DSP SORBS1 HUWE1 TBC1D8 MACF1 ZMYM4 GAB1 | 5.97e-06 | 588 | 119 | 11 | 38580884 |
| Pubmed | USP25 contributes to defective neurogenesis and cognitive impairments. | 6.32e-06 | 11 | 119 | 3 | 37171286 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DNHD1 XRN2 DSP SYNE1 SPTAN1 GEMIN5 HUWE1 OPA1 PHF2 PDIA6 IGF2BP1 TRAP1 PAXBP1 MRPS9 DYNC1H1 MYBPC1 KPNB1 | 7.36e-06 | 1425 | 119 | 17 | 30948266 |
| Pubmed | Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. | 8.63e-06 | 211 | 119 | 7 | 17314511 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | OGT SPTAN1 USP24 USP25 ARFGEF2 GEMIN5 XPNPEP1 HUWE1 PDIA6 TRAP1 AGL UGDH PNMA2 MACF1 USP48 DYNC1H1 KPNB1 | 9.66e-06 | 1455 | 119 | 17 | 22863883 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | XRN2 OGT USP24 TTC27 GEMIN5 HUWE1 ECH1 OPA1 PHF2 IGF2BP1 TRAP1 PAXBP1 MRPS9 DYNC1H1 ARMC6 KPNB1 | 1.13e-05 | 1318 | 119 | 16 | 30463901 |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 22534667 | ||
| Pubmed | Cyclin D1 in excitatory neurons of the adult brain enhances kainate-induced neurotoxicity. | 1.16e-05 | 2 | 119 | 2 | 18585919 | |
| Pubmed | Conservation of the deadenylase activity of proteins of the Caf1 family in human. | 1.16e-05 | 2 | 119 | 2 | 15769875 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 15504908 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 23918382 | ||
| Pubmed | CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma. | 1.16e-05 | 2 | 119 | 2 | 23255553 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 11992406 | ||
| Pubmed | Expression of cyclin D1/2 in the lungs of strain A/J mice fed chemopreventive agents. | 1.16e-05 | 2 | 119 | 2 | 11872634 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 21745168 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 17360629 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 10716990 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 18203920 | ||
| Pubmed | Genetic replacement of cyclin D1 function in mouse development by cyclin D2. | 1.16e-05 | 2 | 119 | 2 | 15657434 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 23940720 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 18431519 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 27843138 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 34102226 | ||
| Pubmed | Diacylglycerol kinase δ controls down-regulation of cyclin D1 for C2C12 myogenic differentiation. | 1.16e-05 | 2 | 119 | 2 | 29859210 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 32224228 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 18417613 | ||
| Pubmed | Discovery and characterization of a novel CCND1/MRCK gene fusion in mantle cell lymphoma. | 1.16e-05 | 2 | 119 | 2 | 27025456 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 10528151 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 29216297 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 27146121 | ||
| Pubmed | CNOT7 Outcompetes Its Paralog CNOT8 for Integration into The CCR4-NOT Complex. | 1.16e-05 | 2 | 119 | 2 | 35248544 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 32663610 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 19605561 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 31230729 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 34521827 | ||
| Pubmed | The targeting of the sole cyclin D1 is not adequate for mantle cell lymphoma and myeloma therapies. | 1.16e-05 | 2 | 119 | 2 | 19679881 | |
| Pubmed | A developmentally regulated switch directs regenerative growth of Schwann cells through cyclin D1. | 1.16e-05 | 2 | 119 | 2 | 10839359 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 28612045 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 10212200 | ||
| Pubmed | A case of interdigitating dendritic cell sarcoma studied by whole-exome sequencing. | 1.16e-05 | 2 | 119 | 2 | 30099721 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 33592173 | ||
| Pubmed | 1.38e-05 | 14 | 119 | 3 | 15836771 | ||
| Pubmed | 1.40e-05 | 151 | 119 | 6 | 17043677 | ||
| Pubmed | 1.53e-05 | 421 | 119 | 9 | 36976175 | ||
| Pubmed | Roquin promotes constitutive mRNA decay via a conserved class of stem-loop recognition motifs. | 1.74e-05 | 45 | 119 | 4 | 23663784 | |
| Pubmed | 2.02e-05 | 549 | 119 | 10 | 38280479 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | XRN2 DSP SYNE1 SPTAN1 XPNPEP1 HUWE1 ECH1 PDIA6 TRAP1 MACF1 DYNC1H1 KPNB1 | 2.21e-05 | 807 | 119 | 12 | 30575818 |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | 2.55e-05 | 344 | 119 | 8 | 36282215 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | KIF13B CDC42BPA EPB41L4B ARFGEF2 ARFGEF1 ADCY9 CASK NOX1 MICAL3 GAB1 | 2.74e-05 | 569 | 119 | 10 | 30639242 |
| Pubmed | 2.92e-05 | 457 | 119 | 9 | 22190034 | ||
| Pubmed | 3.02e-05 | 104 | 119 | 5 | 9205841 | ||
| Pubmed | 3.23e-05 | 463 | 119 | 9 | 34901782 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 15576649 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 19332778 | ||
| Pubmed | Specific functions of BIG1 and BIG2 in endomembrane organization. | 3.47e-05 | 3 | 119 | 2 | 20360857 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 17560576 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 16866877 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 27494902 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 32113162 | ||
| Pubmed | Involvement of the D-type cyclins in germ cell proliferation and differentiation in the mouse. | 3.47e-05 | 3 | 119 | 2 | 11090462 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 12510380 | ||
| Pubmed | The CCR4-NOT complex suppresses untimely translational activation of maternal mRNAs. | 3.47e-05 | 3 | 119 | 2 | 37767629 | |
| Pubmed | Segment- and cell-specific expression of D-type cyclins in the postnatal mouse epididymis. | 3.47e-05 | 3 | 119 | 2 | 22289519 | |
| Pubmed | Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. | 3.47e-05 | 3 | 119 | 2 | 15755896 | |
| Pubmed | Involvement of BIG1 and BIG2 in regulating VEGF expression and angiogenesis. | 3.47e-05 | 3 | 119 | 2 | 31199673 | |
| Pubmed | Enhancement of β-catenin activity by BIG1 plus BIG2 via Arf activation and cAMP signals. | 3.47e-05 | 3 | 119 | 2 | 27162341 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 23386609 | ||
| Pubmed | Contribution of Trp63CreERT2-labeled cells to alveolar regeneration is independent of tuft cells. | 3.47e-05 | 3 | 119 | 2 | 36129169 | |
| Pubmed | The KBTBD6/7-DRD2 axis regulates pituitary adenoma sensitivity to dopamine agonist treatment. | 3.47e-05 | 3 | 119 | 2 | 32572597 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 33021411 | ||
| Pubmed | Homologs of Drosophila Fushi-Tarazu factor 1 map to mouse chromosome 2 and human chromosome 9q33. | 3.47e-05 | 3 | 119 | 2 | 7789992 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 35587057 | ||
| Pubmed | Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screen. | 3.47e-05 | 3 | 119 | 2 | 20090754 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 31560952 | ||
| Pubmed | Serine 62 is a phosphorylation site in folliculin, the Birt-Hogg-Dubé gene product. | 3.47e-05 | 3 | 119 | 2 | 19914239 | |
| Pubmed | Crucial roles of D-type cyclins in the early stage of adipocyte differentiation. | 3.47e-05 | 3 | 119 | 2 | 18374658 | |
| Pubmed | Differential expression of D-type cyclins in HaCaT keratinocytes and in psoriasis. | 3.47e-05 | 3 | 119 | 2 | 17882269 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 23591848 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 27605379 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 24705253 | ||
| Interaction | CTDP1 interactions | 3.39e-06 | 207 | 117 | 9 | int:CTDP1 | |
| Interaction | KCNA3 interactions | DNHD1 CTNNAL1 CDC42BPA DSP USP24 XPNPEP1 OPA1 ADCY9 TBC1D8 PDIA6 MACF1 MICAL3 POLQ EIF2AK3 DYNC1H1 GAB1 KPNB1 | 1.13e-05 | 871 | 117 | 17 | int:KCNA3 |
| Interaction | OTUD7A interactions | 2.17e-05 | 58 | 117 | 5 | int:OTUD7A | |
| GeneFamily | O-linked N-acetylglucosaminyltransferases|Tetratricopeptide repeat domain containing | 1.33e-04 | 4 | 86 | 2 | 446 | |
| GeneFamily | EF-hand domain containing|Plakins | 6.15e-04 | 8 | 86 | 2 | 939 | |
| GeneFamily | PHD finger proteins | 8.93e-04 | 90 | 86 | 4 | 88 | |
| GeneFamily | CCR4-NOT transcription complex | 1.20e-03 | 11 | 86 | 2 | 1023 | |
| GeneFamily | WD repeat domain containing|GRAM domain containing|BEACH domain containing | 1.69e-03 | 13 | 86 | 2 | 1146 | |
| GeneFamily | Ubiquitin specific peptidases | 2.40e-03 | 56 | 86 | 3 | 366 | |
| GeneFamily | Beta 4-glycosyltransferases | 2.90e-03 | 17 | 86 | 2 | 425 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | UBR2 DOK5 OGT RNGTT CDC42BPA USP24 ARFGEF1 CCND1 OPA1 ADCY9 CASK BPTF TMEM131L MACF1 MICAL3 KAT6B ZMYM4 | 2.97e-07 | 856 | 118 | 17 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | UBR2 OGT RNGTT CDC42BPA USP24 ARFGEF1 OPA1 CASK BPTF MICAL3 KAT6B ZMYM4 | 1.35e-06 | 466 | 118 | 12 | M13522 |
| Coexpression | GSE4590_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN | 7.31e-06 | 157 | 118 | 7 | M6871 | |
| Coexpression | GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 3.50e-05 | 200 | 118 | 7 | M6993 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | UBR2 PAIP2 CNPY4 ARFGEF2 HUWE1 ZKSCAN5 OPA1 PSTK TMEM131L FNIP1 MACF1 MICAL3 USP48 EIF2AK3 ZMYM4 | 2.29e-05 | 780 | 116 | 15 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | OGT PNLIPRP1 DSP DGKD HUWE1 CCND2 STMN4 IGF2BP1 SLC22A3 PNMA2 ARHGAP28 KAT6B ZMYM4 ADGRL3 KPNB1 | 3.95e-05 | 818 | 116 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b+.Sp, CD11b CD11c CD45 CD8a CD4, Spleen, avg-2 | CCND1 B4GALT6 TBC1D9 CASK TBC1D8 CSGALNACT2 RASGEF1B TMEM131L MICAL3 ADGRL3 | 4.15e-05 | 376 | 116 | 10 | GSM538266_500 |
| CoexpressionAtlas | Myeloid Cells, DC.4+.Sp, CD11b CD45 CD4 CD11c CD8a, Spleen, avg-1 | CCND1 B4GALT6 TBC1D9 CASK TBC1D8 CSGALNACT2 RASGEF1B TMEM131L MICAL3 ADGRL3 | 4.74e-05 | 382 | 116 | 10 | GSM538248_500 |
| CoexpressionAtlas | Myeloid Cells, DC.4+.Sp, CD11b CD4 CD45 CD11c CD8a, Spleen, avg-1 | CCND1 B4GALT6 TBC1D9 CASK TBC1D8 CSGALNACT2 RASGEF1B TMEM131L MICAL3 ADGRL3 | 4.85e-05 | 383 | 116 | 10 | GSM605826_500 |
| CoexpressionAtlas | Myeloid Cells, DC.4+.Sp, CD11b CD11c CD45 CD8a CD4, Spleen, avg-3 | CCND1 B4GALT6 TBC1D9 CASK TBC1D8 CSGALNACT2 RASGEF1B TMEM131L MICAL3 ADGRL3 | 5.76e-05 | 391 | 116 | 10 | GSM538249_500 |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b+.Sp, CD11b CD4 CD45 CD11c CD8a, Spleen, avg-1 | CCND1 B4GALT6 TBC1D9 CASK TBC1D8 CSGALNACT2 RASGEF1B TMEM131L MICAL3 ADGRL3 | 6.27e-05 | 395 | 116 | 10 | GSM538265_500 |
| CoexpressionAtlas | Myeloid Cells, DC.4+.MLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-3 | CCND1 B4GALT6 TBC1D9 CASK TBC1D8 RASGEF1B TMEM131L ARHGAP28 MICAL3 ADGRL3 | 6.96e-05 | 400 | 116 | 10 | GSM538242_500 |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | KIF13B UBR2 ARFGEF2 HUWE1 B4GALT6 ZNF708 PDIA6 TMEM131L MACF1 POLQ | 1.07e-10 | 191 | 119 | 10 | 9454f642c3621370fa23640b631301346b300950 |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 3.73e-08 | 185 | 119 | 8 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 3.89e-08 | 186 | 119 | 8 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 1.71e-07 | 151 | 119 | 7 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | Control-B_cells-Plasma_cells|Control / group, cell type (main and fine annotations) | 4.64e-07 | 175 | 119 | 7 | fb23858cfce71509cafbe0d9728e678012ff2962 | |
| ToppCell | COVID-19-B_cells-Plasma_cells|COVID-19 / group, cell type (main and fine annotations) | 6.26e-07 | 183 | 119 | 7 | 130c109f63a5e3c8f83cb96e32f4addf513b6415 | |
| ToppCell | COVID-19-B_cells|COVID-19 / group, cell type (main and fine annotations) | 6.26e-07 | 183 | 119 | 7 | 2c016bb59f131a0e821853b085289a3583f0a729 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 7.51e-07 | 188 | 119 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.10e-06 | 199 | 119 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.94e-06 | 172 | 119 | 6 | 80b565f6e37f38629f4cf89d5b053b3b8517244e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_RORB_CARTPT|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.00e-06 | 180 | 119 | 6 | 5e78b29fa1cbdcf502fee3577e5b45766b90d1dc | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.00e-06 | 180 | 119 | 6 | be10fe5bf7c3a671c42704ce7dd8226ab6896794 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.00e-06 | 180 | 119 | 6 | 3b747a517ce75ef2ff09011c037dad7b01ed3e03 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int|lung / Disease (COVID-19 only), tissue and cell type | 1.02e-05 | 184 | 119 | 6 | 480595a0e2e6aa2a77b7daa36490ae3af3d8dfee | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.05e-05 | 185 | 119 | 6 | 3b77bc49cd3740acc025e162a36282ac09e12198 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 1.15e-05 | 188 | 119 | 6 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.15e-05 | 188 | 119 | 6 | 557a0ac069a6ff4e687cac032f64170b9b247165 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.19e-05 | 189 | 119 | 6 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_monocytic-intermediate_monocyte|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.22e-05 | 190 | 119 | 6 | 896b5825edb30fe62cbbed6078570c1f8057a99e | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.34e-05 | 193 | 119 | 6 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_1|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.42e-05 | 195 | 119 | 6 | becad890a420267ca41e98e61a8da343b51e1945 | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.50e-05 | 197 | 119 | 6 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.50e-05 | 197 | 119 | 6 | 9599319dd1f80c81356a8624131566cc76d77d7e | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 1.59e-05 | 199 | 119 | 6 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.64e-05 | 200 | 119 | 6 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.64e-05 | 200 | 119 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.64e-05 | 200 | 119 | 6 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Rgs5_(Mural.Rgs5Acta2.Rgs5)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.52e-05 | 69 | 119 | 4 | a157b1582401cebd222343d94086dbea876140c2 | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Rgs5_(Mural.Rgs5Acta2.Rgs5)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.52e-05 | 69 | 119 | 4 | cdd42abdd072aa438830d837ee857529269a81e0 | |
| ToppCell | control-Plasmablast|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.14e-05 | 165 | 119 | 5 | 61063e0ce61bc92d5d1093be8279af03f650720b | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.86e-05 | 168 | 119 | 5 | f5a18123f84c62211d9279e9c41e90122e4c4895 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-04 | 173 | 119 | 5 | 68bcc0eee15df9cf3516c641709154301bd7b38f | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.07e-04 | 175 | 119 | 5 | 89bf89466191da14896ed8928027f5b911436c22 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 177 | 119 | 5 | 4d2cdb57b427a42085c5f9affa0967b15e84dec3 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____podocyte-2|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 177 | 119 | 5 | 8f0873d348f37c823294b698043319b6608b678a | |
| ToppCell | E17.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.16e-04 | 178 | 119 | 5 | 0139b42494c1186390b12106dea7957e2b6717c2 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.16e-04 | 178 | 119 | 5 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-04 | 179 | 119 | 5 | ba7744b903abfc28b39a00472661f152e9ae39fd | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.22e-04 | 180 | 119 | 5 | 6bb9f41c3a99d1bbe697f589fb2bcea9b7bfbeee | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 181 | 119 | 5 | c7f5aedcb74c21fb587a95a16d700e2a38a380ee | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 181 | 119 | 5 | 0ec9621a078d004bbd25a587757d24b5cf162959 | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 1.26e-04 | 181 | 119 | 5 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.26e-04 | 181 | 119 | 5 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 1.26e-04 | 181 | 119 | 5 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 1.29e-04 | 182 | 119 | 5 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 1.32e-04 | 183 | 119 | 5 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 1.32e-04 | 183 | 119 | 5 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-04 | 183 | 119 | 5 | 612d93df03252d4d2ccdce5a9bc162cfd9172a1a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-04 | 183 | 119 | 5 | eb559ae3ae252d9365c24ef557dd49b78ed6d898 | |
| ToppCell | ILEUM-inflamed-(5)_IgA_plasma_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.32e-04 | 183 | 119 | 5 | a113558ca4220bac31f9336033dff82a618d9258 | |
| ToppCell | nucseq-Immune-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.36e-04 | 184 | 119 | 5 | 911658e7bb499c1bbc8419eec8ff88729bc39a75 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 1.36e-04 | 184 | 119 | 5 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.36e-04 | 184 | 119 | 5 | 942b58ae7172bb5f97e55b032db9329d161854af | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.36e-04 | 184 | 119 | 5 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 184 | 119 | 5 | 1c857126c0ea0671f0d60b048efca288d348d653 | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-Tuft-Tuft|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.39e-04 | 185 | 119 | 5 | 1fbdc96da0623c3935ae9d29dcb4ba9c474e5c21 | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-Tuft|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.39e-04 | 185 | 119 | 5 | b45487daac116e3d3d65ac2b0f81d1bf7d1a1914 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.39e-04 | 185 | 119 | 5 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 1.39e-04 | 185 | 119 | 5 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | Ciliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.43e-04 | 186 | 119 | 5 | f72267d533fd0c5280d9741ceee3dd116300a7e4 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|lung / Disease (COVID-19 only), tissue and cell type | 1.43e-04 | 186 | 119 | 5 | 66676d9395172de5707e204826a1c9f73b448cca | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 186 | 119 | 5 | d8d559daff4aeef334d403fde4e3ee2e4a6086d0 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.46e-04 | 187 | 119 | 5 | a716b64ca03d9b61da765bf87f065ac9393303f1 | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|IPF / Disease state, Lineage and Cell class | 1.46e-04 | 187 | 119 | 5 | 19d6a404fc3651d98a93e3848e372df51a239c57 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.46e-04 | 187 | 119 | 5 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-04 | 187 | 119 | 5 | 24c2a3962da364e46e98abeab5f8234376fa26bb | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.50e-04 | 188 | 119 | 5 | 599195338070ac6b79bd114609d9e10cac4f1df4 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.50e-04 | 188 | 119 | 5 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-04 | 188 | 119 | 5 | c2101ded71fb16b8ddbc1f883911b1ed2a533ffc | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.50e-04 | 188 | 119 | 5 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-04 | 188 | 119 | 5 | 3b8b9161f0fdcbde302ce5b4c0bc874628211109 | |
| ToppCell | COPD-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 1.50e-04 | 188 | 119 | 5 | 9ffef4b01d0ddd6913c9ed6be79aeaaabd5e41ed | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_memory|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.50e-04 | 188 | 119 | 5 | b6ae707b033a17c75ca81f9194631ead1b63d170 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-04 | 188 | 119 | 5 | 1b349618f77260564486586b7f5a47a77d12859c | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.50e-04 | 188 | 119 | 5 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | IPF-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 1.54e-04 | 189 | 119 | 5 | 7a260485c2a7c743c14d048e5e480ae0a9b8e32c | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.54e-04 | 189 | 119 | 5 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | ILEUM-inflamed-(5)_IgM_plasma_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.54e-04 | 189 | 119 | 5 | fa9387d120cde6416998234c6ebd0ef74deed768 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 1.54e-04 | 189 | 119 | 5 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 1.54e-04 | 189 | 119 | 5 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.54e-04 | 189 | 119 | 5 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.54e-04 | 189 | 119 | 5 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.58e-04 | 190 | 119 | 5 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 190 | 119 | 5 | 251e3a33041023bfc4b547c7eb68cfb8f421636f | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_myocytic-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.58e-04 | 190 | 119 | 5 | 81f8f2cddf4c51b879f315260cd1fca80355a371 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_myocytic-stroma-muscle|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.58e-04 | 190 | 119 | 5 | 20106e5213f6a7560554b8b4f84b23c5554ba975 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.58e-04 | 190 | 119 | 5 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | control-Myeloid-Immature_Neutrophils_1|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.58e-04 | 190 | 119 | 5 | 38e83337c70c8734b63f8589ba59e0f98603f94c | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_myocytic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.58e-04 | 190 | 119 | 5 | 877b544decf302e0d41be23dffa1861f79c70914 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.62e-04 | 191 | 119 | 5 | fca19f2719806f3dc2dd2add7252ab1198548f4d | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.62e-04 | 191 | 119 | 5 | d4f77c73311d1149466bbfe4adbd6a301946ec90 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.62e-04 | 191 | 119 | 5 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.62e-04 | 191 | 119 | 5 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | (12)_SLC16A7+|World / shred by cell type by condition | 1.62e-04 | 191 | 119 | 5 | e427eeddd2e87c14376a37db0b43f120c90436bc | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.62e-04 | 191 | 119 | 5 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | 3'-Child09-12-SmallIntestine-Neuronal-Glial_mature|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.65e-04 | 192 | 119 | 5 | ac507fd7cf3b3e521a15ef03bb4e81eb23807985 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.65e-04 | 192 | 119 | 5 | 072281344d58e85c9a290750b488d0c101f75d54 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Neuronal|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.65e-04 | 192 | 119 | 5 | 24f40dadec04f4f99c31000fa9f09d07148fa190 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Neuronal-Glial_mature-Adult_Glia|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.65e-04 | 192 | 119 | 5 | 71e04e197825856c6d4278fc76c58ab17ffa2387 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-04 | 192 | 119 | 5 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.56e-05 | 50 | 76 | 5 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Drug | Propidium iodide [25535-16-4]; Up 200; 6uM; HL60; HT_HG-U133A | 8.84e-06 | 197 | 118 | 8 | 2541_UP | |
| Drug | Eserine sulfate, physostigmine sulfate [64-47-1]; Down 200; 6.2uM; MCF7; HT_HG-U133A | 8.84e-06 | 197 | 118 | 8 | 2768_DN | |
| Drug | Butamben [94-25-7]; Up 200; 20.6uM; HL60; HT_HG-U133A | 9.18e-06 | 198 | 118 | 8 | 2531_UP | |
| Disease | syndromic X-linked intellectual disability (implicated_via_orthology) | 3.35e-06 | 8 | 117 | 3 | DOID:0060309 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | PNLIPRP1 SYNE1 SPTAN1 MCF2L2 ARFGEF2 CCND1 SORBS1 PFKFB4 OTOGL PRKAA1 MACF1 TEKT4 KAT6B GAB1 | 9.28e-05 | 1074 | 117 | 14 | C0006142 |
| Disease | nephrotic syndrome type 20 (implicated_via_orthology) | 9.30e-05 | 4 | 117 | 2 | DOID:0070357 (implicated_via_orthology) | |
| Disease | invasive lobular carcinoma (is_implicated_in) | 9.30e-05 | 4 | 117 | 2 | DOID:3457 (is_implicated_in) | |
| Disease | loneliness measurement | 1.39e-04 | 124 | 117 | 5 | EFO_0007865 | |
| Disease | waist circumference | 3.21e-04 | 429 | 117 | 8 | EFO_0004342 | |
| Disease | colon adenoma (is_marker_for) | 3.23e-04 | 7 | 117 | 2 | DOID:0050912 (is_marker_for) | |
| Disease | multiple myeloma (is_marker_for) | 3.94e-04 | 36 | 117 | 3 | DOID:9538 (is_marker_for) | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.00e-03 | 12 | 117 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | Drug habituation | 1.16e-03 | 115 | 117 | 4 | C0013170 | |
| Disease | Substance-Related Disorders | 1.16e-03 | 115 | 117 | 4 | C0236969 | |
| Disease | Drug abuse | 1.16e-03 | 115 | 117 | 4 | C0013146 | |
| Disease | Drug Use Disorders | 1.16e-03 | 115 | 117 | 4 | C0013222 | |
| Disease | Drug Dependence | 1.16e-03 | 115 | 117 | 4 | C1510472 | |
| Disease | Substance Dependence | 1.16e-03 | 115 | 117 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 1.16e-03 | 115 | 117 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.16e-03 | 115 | 117 | 4 | C0029231 | |
| Disease | Prescription Drug Abuse | 1.16e-03 | 115 | 117 | 4 | C4316881 | |
| Disease | Substance abuse problem | 1.19e-03 | 116 | 117 | 4 | C0740858 | |
| Disease | rostral middle frontal gyrus volume measurement | 1.38e-03 | 14 | 117 | 2 | EFO_0010328 | |
| Disease | body weight | EPB41L4B NBEAL1 HUWE1 ADCY9 CCND2 TRIM66 BPTF STMN4 SLC22A3 FNIP1 KAT6B EIF2AK3 KPNB1 | 1.50e-03 | 1261 | 117 | 13 | EFO_0004338 |
| Disease | partial epilepsy | 2.04e-03 | 17 | 117 | 2 | EFO_0004263 | |
| Disease | muscular dystrophy (is_implicated_in) | 2.04e-03 | 17 | 117 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | 1-Methylhistidine measurement | 2.04e-03 | 17 | 117 | 2 | EFO_0021543 | |
| Disease | phospholipids:total lipids ratio | 2.15e-03 | 227 | 117 | 5 | EFO_0020946 | |
| Disease | food allergy measurement, parental genotype effect measurement | 2.29e-03 | 18 | 117 | 2 | EFO_0005939, EFO_0007016 | |
| Disease | coronary artery disease | SORBS2 NBEAL1 CNPY4 ARFGEF2 XKR4 PHF2 IGF2BP1 TMEM132D SLC22A3 RASGEF1B USP48 ADGRL3 | 2.81e-03 | 1194 | 117 | 12 | EFO_0001645 |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 3.36e-03 | 364 | 117 | 6 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | body fat percentage | 3.38e-03 | 488 | 117 | 7 | EFO_0007800 | |
| Disease | impotence (biomarker_via_orthology) | 3.42e-03 | 22 | 117 | 2 | DOID:1875 (biomarker_via_orthology) | |
| Disease | proprotein convertase subtilisin/kexin type 9 measurement | 3.42e-03 | 22 | 117 | 2 | EFO_0009312 | |
| Disease | Nasopharyngeal carcinoma | 3.42e-03 | 22 | 117 | 2 | C2931822 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SMVCIIDDREDVWKF | 296 | Q9Y5B0 | |
| CETMLEEFEDIVGDW | 156 | Q8N129 | |
| LKDWMNGRCTIEERE | 896 | Q9NZJ5 | |
| EFMKCLDGNIVSWEE | 196 | Q8IZF6 | |
| EEVSLVEWLDVKYCM | 881 | Q8N7X0 | |
| VDFVRWLCAVSMDEL | 1141 | Q9Y6D6 | |
| EACWALRVMTFDDDI | 241 | Q6NXE6 | |
| MLRVWCKLEDFQEVS | 231 | Q9UNA3 | |
| ESCEAVEAREIMWFK | 496 | Q9HAR2 | |
| AIVDFVRWLCAVSMD | 1086 | Q9Y6D5 | |
| ATWMLEVCEEQKCEE | 61 | P24385 | |
| RVISENISEWKCMAF | 1026 | Q96M86 | |
| YWEAELCKILEEMRE | 511 | Q12830 | |
| EMRHVDCQSVWDAFK | 76 | P28907 | |
| EVLMRVLADCDSWED | 241 | Q6ZS30 | |
| DMDSEEKEIVVWVCQ | 21 | O75901 | |
| LWEEEFIERCFQEML | 51 | Q9BPZ3 | |
| ESEMIFDWVDVERKG | 81 | Q7Z6P3 | |
| RAVADSWMEEVIKLC | 21 | P04090 | |
| KEAERLMEQASCWEK | 1006 | Q8WYB5 | |
| TWMLEVCEEQKCEEE | 61 | P30279 | |
| RKCAESFEMWDDRDS | 241 | Q9Y5S8 | |
| ELQEWRVACIAMEKT | 676 | O14936 | |
| SDLVEEFWMKSAEIR | 1321 | Q7RTP6 | |
| NCVAEEEVWKVFNTM | 216 | Q96LZ2 | |
| LICAFLVEKMDWSIE | 136 | O60942 | |
| DVWELMSQECRDEVV | 181 | Q9H3C7 | |
| LVADSEEEMNKWVRC | 96 | Q13480 | |
| RQEEAMKAEKWLFEC | 376 | Q96ED9 | |
| FVDCPDEHWAMKAIE | 41 | Q9NZI8 | |
| IRDCWFSEISKLLME | 941 | Q86YR7 | |
| DESWVTDMCKKLFEV | 101 | P54315 | |
| WKVLNEIDAGVCEEM | 321 | Q16877 | |
| WREMVECFNKISRDA | 86 | Q13011 | |
| DQMVFFWEDIKARAE | 2106 | O94854 | |
| SDLEADEWCKVLQME | 96 | Q9P104 | |
| VFKCVRWMHFTEEDQ | 261 | Q8WVZ9 | |
| LEDWCRIMSVDEQKS | 6 | Q9UL42 | |
| EAKCRDFENMLWFES | 641 | Q9Y5B6 | |
| EFMTWKQVECPFERD | 411 | Q0VAM2 | |
| WTEECKVLDAESMHD | 2651 | Q7Z6Z7 | |
| EQLSMEKEVVRVWFC | 316 | Q9UKI9 | |
| LMEANCASEEKIWEV | 206 | A6NCF6 | |
| WAPVRSTMCFEKEVE | 571 | Q5T6X5 | |
| LAVSDCFWKMVRESV | 546 | O60313 | |
| CFWKMVRESVEQQAD | 551 | O60313 | |
| RICEVWACNLDEEMK | 11 | Q9UIV1 | |
| WDKGEVLMFFCDVDI | 356 | Q8N6G5 | |
| EKKYSDCAWEVVRME | 156 | P05000 | |
| LDVFCEAWESQISDM | 501 | Q9UBT7 | |
| MKDSVWDCVIFHDVD | 216 | Q9UBX8 | |
| CFLEETADEWAEKMP | 1136 | Q5THR3 | |
| EAVCIIADMDKWTVQ | 1046 | Q8TF40 | |
| ADVFRSIAAEWKMIE | 2356 | O75417 | |
| REIMWINDCEEEELL | 281 | P15924 | |
| MEDCEEWRVQLKALV | 336 | Q5T5S1 | |
| EDVMACTKRLLEWIA | 846 | O60503 | |
| EFWSNVCDEEMDLAI | 281 | Q14974 | |
| LCADNRKEMEDWIAA | 126 | Q16760 | |
| KVMVACFEVFQTWDD | 411 | Q14204 | |
| VICEVWASNLEEEMR | 11 | Q9UFF9 | |
| ECAKLVWEEAMSRFC | 231 | Q16610 | |
| VWEEAMSRFCEAEFS | 236 | Q16610 | |
| KDGIVELWDDMFERC | 921 | Q6ZMW3 | |
| ECCNDMTVWRKVSEA | 96 | Q8TAA1 | |
| CFVGSEDIAKDMEAW | 206 | Q9NV23 | |
| WMDDVACKGTEETIF | 456 | Q6ZMJ2 | |
| VSEFDLVCVNAWMLD | 141 | O75751 | |
| TEAMEFDIFQRWKEC | 236 | Q9H329 | |
| VFKCVRWMHFTEEDQ | 261 | Q86V97 | |
| FIESWEIEKSFEVTM | 1711 | Q3ZCN5 | |
| DKNVLDSEDVWMVEF | 171 | Q15084 | |
| VCDWTDYDERMKKLV | 476 | O15294 | |
| EAKASKIFNCRMEWE | 166 | O95157 | |
| IEWMIKDGCEVDVVD | 226 | Q8TC84 | |
| LDMRDLYQEWKECEE | 761 | Q9NQT8 | |
| IVDWARRCMVFKELE | 276 | Q13285 | |
| VTRFMIECDACKDWF | 16 | O75151 | |
| FLEKCETWMEFLVQT | 7461 | Q8NF91 | |
| AKEDICTDAMRENWI | 1016 | A2VDJ0 | |
| VMSSEDDIKWVCQDL | 1066 | Q14C87 | |
| VAFIRMEKDDDFTTW | 576 | Q8WZA1 | |
| GMWRDEKVSLYCDEV | 116 | Q9BZQ2 | |
| LNREHKETCEMDWSD | 191 | Q8WW24 | |
| EADTVDLNWCVISDM | 36 | Q9H169 | |
| WEMLKRAETACFREE | 111 | Q5VT25 | |
| VLMKRTWREAEAFCE | 686 | Q13018 | |
| DVIDVMEKCDDGWFV | 1066 | O94875 | |
| MAEVCRAIKQLDYEW | 421 | Q13131 | |
| VVICTEWDMFKELDY | 411 | O60701 | |
| MIDVDSLTDKECDWL | 571 | Q9NQW7 | |
| FMDVAIEFSVEEWQC | 6 | A8MTY0 | |
| GDVEWKSCDLEEVMV | 371 | Q9NZQ8 | |
| ALCSFVTEDEVEWMR | 351 | P82933 | |
| ASMEDFWREIESIKD | 76 | Q9P2N2 | |
| RECEDVMDWINDKEA | 156 | Q13813 | |
| FADANEAESWMREKE | 896 | Q13813 | |
| RTEAMWEDFITCLKD | 106 | Q8IV42 | |
| EEEAFWLLVAVCERM | 606 | O95759 | |
| DIVDVMEKCDDGWFV | 1256 | Q9BX66 | |
| FDVERSIDDWVFMCF | 326 | Q9H0D6 | |
| EEEAFWLLVALCERM | 616 | Q6ZT07 | |
| SMDRDVKCWDIATLE | 356 | Q8TEQ6 | |
| EKDILAVEDMRNRWC | 976 | Q9UHP3 | |
| TEFCITKWEEIVFDM | 421 | Q5GH76 | |
| QDAKACAEMISTWVE | 141 | O75830 | |
| FMDVAIEFSLEEWQC | 6 | P17019 | |
| AECLSEKETEELMAW | 571 | Q12931 | |
| ELDREMCFEWFTKGQ | 746 | Q9UPU5 | |
| MDVAIEFSQEEWKCL | 11 | Q3MIS6 | |
| DLIWLCQMDTEKEVE | 246 | Q9BQ83 | |
| DVFLVWQEMEEACST | 336 | Q502W6 | |
| KVDDDALLVFWDARM | 136 | Q96FK6 | |
| QIFEKLEMWEDVVIC | 461 | Q6P3X3 | |
| LEMWEDVVICYERAG | 466 | Q6P3X3 | |
| EEVVSDVRLMFWNCA | 1106 | O15016 | |
| MQDWCASDEKVLIEA | 551 | Q8IWV8 | |
| DRDNSKFEEWCIEMA | 441 | Q86UV5 | |
| WEVHMREKSFECIQS | 206 | Q5VIY5 | |
| MFSRIEEEHLWECKQ | 1356 | Q5VZL5 | |
| FIVKVEEEDCTWMQE | 26 | Q9Y2L8 | |
| AIEECCNWFHKRMEE | 366 | P35573 | |
| WMRLNFDLCKETTFE | 666 | Q00872 |